Sthuneyaka: Benefits, Evidence & Safety

TL;DR

Sthuneyaka (Costus speciosus), a ginger-like herb of the Costus family, is described in Ayurvedic lexicons as fever-reducing and worm-dispelling. Rat studies of its root and rhizome extracts show dose-dependent blood-sugar lowering with higher insulin levels, but no human trials exist: so it is not a proven diabetes treatment.

(49 words. Sources: PMC animal study; J-Stage animal study; IJCRT literary review.)

What it is

Sthuneyaka is a Sanskrit name for Costus speciosus (L.) Sm., a tall, ginger-like perennial herb in the Costaceae family with a fleshy underground rhizome. It also appears in botanical literature under the synonyms Cheilocostus speciosus and Hellenia speciosa, and in Ayurvedic sources under the related name Kebuka (IJCRT literary review). The rhizome (root) and leaves are the parts used in research and traditional practice.

The plant is a source of the sesquiterpene lactone eremanthin, isolated from C. speciosus and studied as one of its active constituents (University of Nairobi repository).

Traditional use

A peer-reviewed literary review of classical Ayurvedic references identifies Sthūneyaka as Costus speciosus (Costaceae), listed in the Madanapala Nighantu (Sugandhādi varga) and the Kaiyadeva Nighantu (Auṣadha varga) with the actions jantujit (dispelling worms/microbes) and jvaraghna (reducing fever) (IJCRT). These are traditional textual claims, not clinical proof: the modern evidence, all from animal studies, is assessed below.

What modern research says

Blood-sugar lowering (animal)

In streptozotocin-induced diabetic male rats, an ethanolic root extract of C. speciosus lowered blood glucose in a dose-dependent manner, the high dose (600 mg/kg) performing comparably to the reference drug glibenclamide, while raising serum insulin and increasing the expression of genes for insulin-1, the insulin receptor, glucokinase, and the glucose transporter GLUT2 (PMC). This suggests an insulin-supporting mechanism in rats, not a diabetes treatment in humans.

Blood sugar, lipids, and kidney markers (animal)

A separate 60-day study in streptozotocin-diabetic Wistar rats tested hexane, ethyl acetate, and methanol rhizome extracts (250, 400, and 400 mg/kg respectively): all three significantly lowered plasma glucose versus controls, and the hexane extract additionally reduced glycosylated hemoglobin (HbA1c), total cholesterol, triglycerides, urea, uric acid, and creatinine while raising plasma insulin, tissue glycogen, and HDL cholesterol and normalizing liver enzymes (Journal of Health Science, J-Stage). Rodent biochemistry is not human efficacy.

Eremanthin (animal)

Eremanthin, isolated from C. speciosus, was given to streptozotocin-diabetic male Wistar rats at 5, 10, and 20 mg/kg for 60 days: plasma glucose fell dose-dependently, and at 20 mg/kg it also lowered HbA1c, total and LDL cholesterol, and triglycerides while raising plasma insulin, tissue glycogen, and HDL (University of Nairobi repository). An isolated-constituent rat study is still preclinical evidence.

What the evidence does not support (yet)

No randomized human trials of Costus speciosus or eremanthin were found. The blood-sugar and lipid effects all come from diabetic-rat models, and animal doses cannot be converted into human doses. Claims that Sthuneyaka treats diabetes, lowers cholesterol, or replaces diabetes medication in people are ahead of the data.

Safety & contraindications

Safety data is limited: talk to a clinician. No human safety studies of Costus speciosus were found: there is no established human dose and no data on pregnancy, breastfeeding, or interactions with diabetes medications. Because animal studies show blood-sugar-lowering activity, combining it with glucose-lowering drugs could theoretically cause low blood sugar: anyone with diabetes should not add it without medical supervision.

FAQs

What is Sthuneyaka?

Sthuneyaka is the Sanskrit name for Costus speciosus, a tall ginger-like herb in the Costaceae family with a fleshy rhizome, also known in Ayurvedic sources as Kebuka and in modern taxonomy as Cheilocostus speciosus or Hellenia speciosa (IJCRT literary review). Classical lexicons credit it with fever-reducing and worm-dispelling actions.

Can Sthuneyaka treat diabetes?

Not proven. Diabetic-rat studies show that root and rhizome extracts lower blood glucose dose-dependently and raise insulin levels (PMC; J-Stage), but no human trials exist. It must not replace prescribed diabetes medication, and anyone with diabetes should consult their doctor before considering it.

What is eremanthin?

Eremanthin is a sesquiterpene lactone isolated from Costus speciosus and studied as one of the plant's active constituents. In diabetic rats, 60 days of oral eremanthin lowered blood glucose, HbA1c, and blood lipids while raising insulin (University of Nairobi repository). It is a research compound, not an available medicine, and its effects have only been shown in animals.

Is Sthuneyaka safe?

Safety data is limited: talk to a clinician. With no human studies, there is no established dose and no pregnancy, breastfeeding, or interaction data. Because animal research shows glucose-lowering activity, there is a theoretical risk of low blood sugar if combined with diabetes drugs (PMC).

How is Sthuneyaka traditionally used?

Classical Ayurvedic lexicons, the Madanapala Nighantu and Kaiyadeva Nighantu, list Sthūneyaka (Costus speciosus) as jantujit (dispelling worms and microbes) and jvaraghna (alleviating fever) (IJCRT). These are traditional textual descriptions; modern research has instead focused on its metabolic effects in animals.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.